PB 133 of 2022
National Health (April 2023 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2022
National Health Act 1953
I, DAVID LAFFAN, Acting First Assistant Secretary, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care make this determination under subsection 99ACC(5C) and subsection 99ACF(3) of the National Health Act 1953.
Dated 21 December 2022
DAVID LAFFAN
Acting First Assistant Secretary
Technology Assessment and Access Division
Health Resourcing Group
Department of Health and Aged Care
1 Name of Determination
(1) This instrument is the National Health (April 2023 Price Reductions) (Exercise of Ministerial discretion) Determination (No.1) 2022.
(2) This instrument may also be cited as PB 133 of 2022.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | The day this instrument is registered. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Definition
Note: A number of expressions used in this instrument are defined in Part VII the Act.
In this instrument:
Act means the National Health Act 1953.
catch-up price reduction day has the same meaning as in subsection 99ACN(6) of the Act.
4 Authority
This instrument is made under subsection 99ACC(5C) and subsection 99ACF(3) of the Act.
5 Brand of pharmaceutical item (combination item) not subject to a price reduction
I determine, under paragraph 99ACC(5C)(a) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each single brand of combination item specified in column 2 as an item in the table in Schedule 1 is not reduced under subsection 99ACC(2) or subsection 99ACC(5) of the Act, as appropriate, in relation to the reduction day.
6 Brand of pharmaceutical item not subject to a price reduction
I determine, under paragraph 99ACF(3)(a) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of each brand of pharmaceutical item specified in column 2 as an item in the table in Schedule 2 is not reduced under a provision mentioned in item 2A or item 3A or item 4A or item 8 of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the catch-up price reduction day.
7 Brand of pharmaceutical item subject to a lower price reduction than would otherwise apply
I determine, under paragraph 99ACF(3)(b) of the Act, that the approved ex-manufacturer price, and each of the claimed prices (if applicable) of a brand of pharmaceutical item specified in column 2 of an item in the table in Schedule 3 is reduced under a provision mentioned in item 4A or item 8 of the table in subsection 99ACF(1) of the Act, as appropriate, in relation to the catch-up price reduction day by the percentage specified in column 3 of the table item.
Schedule 1 — Brands of pharmaceutical items (combination items) with approved ex-manufacturer price not reduced
Column 1 | Column 2 | |||
Item | Brand of Combination Item | |||
| Drug | Form | Manner of administration | Brand(s) |
1 | Atovaquone with proguanil | Tablet containing atovaquone 250 mg with proguanil hydrochloride 100 mg | Oral | Malarone |
2 | Insulin degludec with insulin aspart | Injections, cartridges, 70 units-30 units per mL, 3 mL, 5 | Injection | Ryzodeg Penfill |
3 | Insulin degludec with insulin aspart | Injections, pre-filled pen, 70 units-30 units per mL, 3 mL, 5 | Injection | Ryzodeg Flextouch |
Schedule 2— Brands of pharmaceutical items with approved ex-manufacturer price not reduced
Column 1 | Column 2 | |||
Item | Brand of Pharmaceutical Item | |||
| Drug | Form | Manner of administration | Brand(s) |
1 | Abacavir | Oral solution 20 mg (as sulfate) per mL, 240 mL | Oral | Ziagen |
2 | Adrenaline (epinephrine) | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Adrenaline Jr Viatris |
3 | Adrenaline (epinephrine) | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Anapen Junior 150 |
4 | Adrenaline (epinephrine) | I.M. injection 150 micrograms in 0.3 mL single dose syringe auto-injector | Injection | EpiPen Jr. |
5 | Adrenaline (epinephrine) | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Adrenaline Viatris |
6 | Adrenaline (epinephrine) | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Anapen 300 |
7 | Adrenaline (epinephrine) | I.M. injection 300 micrograms in 0.3 mL single dose syringe auto-injector | Injection | EpiPen |
8 | Adrenaline (epinephrine) | I.M. injection 500 micrograms in 0.3 mL single dose syringe auto-injector | Injection | Anapen 500 |
9 | Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Oral powder 400 g (GA1 Anamix infant) | Oral | GA1 Anamix Infant |
10 | Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Oral powder 500 g (XLYS, LOW TRY Maxamum) | Oral | XLYS LOW TRY Maxamum |
11 | Amino acid formula with vitamins and minerals without lysine and low in tryptophan | Sachets containing oral powder 18 g, 30 (GA1 Anamix Junior) | Oral | GA1 Anamix Junior |
12 | Amino acid formula with vitamins and minerals without methionine | Oral liquid 125 mL, 30 (HCU Lophlex LQ 20) | Oral | HCU Lophlex LQ 20 |
13 | Amino acid formula with vitamins and minerals without methionine | Oral liquid 174 mL, 30 (HCU cooler 20) | Oral | HCU cooler 20 |
14 | Amino acid formula with vitamins and minerals without methionine | Oral powder 400 g (HCU Anamix infant) | Oral | HCU Anamix Infant |
15 | Amino acid formula with vitamins and minerals without methionine | Sachets containing oral powder 25 g, 30 (HCU express 15) | Oral | HCU express 15 |
16 | Amino acid formula with vitamins and minerals without methionine | Sachets containing oral powder 29 g, 30 (HCU Lophlex) | Oral | HCU Lophlex |
17 | Amino acid formula with vitamins and minerals without methionine | Sachets containing oral powder 36 g, 30 (HCU Anamix Junior) | Oral | HCU Anamix Junior |
18 | Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Oral powder 400 g (MMA/PA Anamix infant) | Oral | MMA/PA Anamix Infant |
19 | Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Sachets containing oral powder 18 g, 30 (MMA/PA Anamix Junior) | Oral | MMA/PA Anamix Junior |
20 | Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine | Sachets containing oral powder 25 g, 30 (MMA/PA express 15) | Oral | MMA/PA express 15 |
21 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 125 mL, 30 (PKU Lophlex LQ 20) | Oral | PKU Lophlex LQ 20 |
22 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 125 mL, 36 (PKU Anamix Junior LQ) | Oral | PKU Anamix Junior LQ |
23 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 130 mL, 30 (PKU Cooler 15) | Oral | PKU Cooler 15 |
24 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 174 mL, 30 (PKU Air 20) | Oral | PKU Air 20 |
25 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 174 mL, 30 (PKU Cooler 20) | Oral | PKU Cooler 20 |
26 | Amino acid formula with vitamins and minerals without phenylalanine | Oral liquid 87 mL, 30 (PKU Cooler 10) | Oral | PKU Cooler 10 |
27 | Amino acid formula with vitamins and minerals without phenylalanine | Oral powder 500 g (XP Maxamum) | Oral | XP Maxamum |
28 | Amino acid formula with vitamins and minerals without phenylalanine | Oral semi-solid 109 g, 36 (PKU Lophlex Sensation 20) | Oral | PKU Lophlex Sensation 20 |
29 | Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 25 g, 30 (PKU express 15) | Oral | PKU express 15 |
30 | Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 28 g, 30 (PKU Lophlex) | Oral | PKU Lophlex |
31 | Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 34 g, 30 (PKU express 20) | Oral | PKU express 20 |
32 | Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 36 g, 30 (PKU Anamix Junior) | Oral | PKU Anamix Junior |
33 | Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Oral liquid 174 mL, 30 (TYR cooler 20) | Oral | TYR cooler 20 |
34 | Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Oral powder 400 g (TYR Anamix infant) | Oral | TYR Anamix infant |
35 | Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Sachets containing oral powder 28 g, 30 (TYR Lophlex) | Oral | TYR Lophlex |
36 | Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Sachets containing oral powder 36 g, 30 (TYR Anamix Junior) | Oral | TYR Anamix Junior |
37 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral liquid 125 mL, 30 (MSUD Lophlex LQ 20) | Oral | MSUD Lophlex LQ 20 |
38 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral liquid 130 mL, 30 (MSUD cooler 15) | Oral | MSUD cooler 15 |
39 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral liquid 174 mL, 30 (MSUD cooler 20) | Oral | MSUD cooler 20 |
40 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral powder 400 g (MSUD Anamix infant) | Oral | MSUD Anamix infant |
41 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Oral powder 500 g (MSUD Maxamum) | Oral | MSUD Maxamum |
42 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Sachets containing oral powder 25 g, 30 (MSUD express 15) | Oral | MSUD express 15 |
43 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Sachets containing oral powder 28 g, 30 (MSUD Lophlex) | Oral | MSUD Lophlex |
44 | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior) | Oral | MSUD Anamix Junior |
45 | Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine | Oral powder 400 g (PKU Anamix infant) | Oral | PKU Anamix Infant |
46 | Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine | Oral powder 400 g (PKU Start) | Oral | PKU Start |
47 | Amino acid formula without phenylalanine | Tablets 1 g, 75 (Phlexy-10) | Oral | Phlexy- 10 |
48 | Amino acid synthetic formula supplemented with long chain polyunsaturated fatty acids | Oral powder 400 g (Neocate LCP) | Oral | Neocate LCP |
49 | Amino acids-synthetic, formula | Oral powder 400 g (EleCare) | Oral | EleCare |
50 | Amino acids-synthetic, formula | Oral powder 400 g (Neocate Junior Vanilla) | Oral | Neocate Junior Vanilla |
51 | Apomorphine | Injection containing apomorphine hydrochloride hemihydrate 100 mg in 20 mL | Injection | Apomine Solution for Infusion |
52 | Apomorphine | Solution for subcutaneous infusion containing apomorphine hydrochloride hemihydrate 50 mg in 10 mL pre-filled syringe | Injection | Movapo PFS |
53 | Apomorphine | Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen | Injection | Apomine Intermittent |
54 | Apomorphine | Solution for subcutaneous injection containing apomorphine hydrochloride 30 mg in 3 mL pre-filled pen | Injection | Movapo Pen |
55 | Atovaquone | Oral suspension 750 mg per 5 mL, 210 mL | Oral | Wellvone |
56 | Atropine | Eye drops containing atropine sulfate monohydrate 10 mg per mL, 15 mL | Application to the Eye | Atropt |
57 | Atropine | Injection containing atropine sulfate monohydrate 600 micrograms in 1 mL | Injection | Pfizer Australia Pty Ltd |
58 | Auranofin | Capsule 3 mg | Oral | Ridaura |
59 | Benzathine benzylpenicillin | Injection containing 600,000 units benzathine benzylpenicillin tetrahydrate in 1.17 mL single use pre-filled syringe | Injection | Bicillin L-A |
60 | Benzathine benzylpenicillin | Injection containing 1,200,000 units benzathine benzylpenicillin tetrahydrate in 2.3 mL single use pre-filled syringe | Injection | Bicillin L-A |
61 | Benzatropine | Injection containing benzatropine mesilate 2 mg in 2 mL | Injection | Benzatropine Injection |
62 | Benzylpenicillin | Powder for injection 3 g (as sodium) | Injection | BenPen |
63 | Benzylpenicillin | Powder for injection 600 mg (as sodium) | Injection | BenPen |
64 | Betamethasone | Injection containing betamethasone acetate 3 mg with betamethasone sodium phosphate 3.9 mg in 1 mL | Injection | Celestone Chronodose |
65 | Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoptic
|
66 | Betaxolol | Eye drops, solution, 5 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Betoquin |
67 | Budesonide | Capsule (modified release) 3 mg | Oral | Entocort |
68 | Bupropion | Tablet containing bupropion hydrochloride 150 mg (sustained release) | Oral | Zyban |
69 | Busulfan | Tablet 2 mg | Oral | Myleran |
70 | Cabergoline | Tablet 500 micrograms | Oral | Dostinex |
71 | Calcitonin salmon | Injection 100 I.U. in 1 mL | Injection | Miacalcic 100 |
72 | Carbohydrate, fat, vitamins, minerals and trace elements | Oral powder 400 g (Energivit) | Oral | Energivit |
73 | Chlorambucil | Tablet 2 mg | Oral | Leukeran |
74 | Chlorpromazine | Injection containing chlorpromazine hydrochloride 50 mg in 2 mL | Injection | Largactil |
75 | Chlorpromazine | Oral solution containing chlorpromazine hydrochloride 25 mg per 5 mL, 100 mL | Oral | Largactil |
76 | Chlorpromazine | Tablet containing chlorpromazine hydrochloride 100 mg | Oral | Largactil |
77 | Choriogonadotropin alfa | Solution for injection 250 micrograms in 0.5 mL pre-filled pen | Injection | Ovidrel |
78 | Ciclosporin | Eye drops 1 mg per mL, single dose units 0.3 mL, 30 | Application to the Eye | Ikervis |
79 | Ciprofloxacin | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the Eye | CiloQuin
|
80 | Ciprofloxacin | Eye drops 3 mg (as hydrochloride) per mL, 5 mL | Application to the Eye | Ciloxan |
81 | Cortisone | Tablet containing cortisone acetate 5 mg | Oral | Cortate |
82 | Cortisone | Tablet containing cortisone acetate 25 mg | Oral | Cortate |
83 | Cyclophosphamide | Tablet 50 mg (anhydrous) | Oral | Cyclonex |
84 | Cytarabine | Injection 100 mg in 5 mL vial | Injection | Pfizer Australia Pty Ltd |
85 | Dapsone | Tablet 25 mg | Oral | Link Medical Products Pty Ltd |
86 | Dapsone | Tablet 100 mg | Oral | Link Medical Products Pty Ltd |
87 | Deferiprone | Tablet 500 mg | Oral | Ferriprox |
88 | Deferiprone | Tablet 1000 mg | Oral | Ferriprox |
89 | Deferiprone | Oral solution 100 mg per mL, 250 mL | Oral | Ferriprox |
90 | Dexamethasone | Tablet 4 mg | Oral | Dexmethsone |
91 | Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg | Oral | Aspen Pharma Pty Ltd |
92 | Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | Injection | ADT Booster |
93 | Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Clexane Safety-Lock |
94 | Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Clexane Safety-Lock |
95 | Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Safety-Lock |
96 | Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Clexane Safety-Lock |
97 | Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Safety-Lock |
98 | Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Mayne Pharma Erythromycin |
99 | Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Eryc |
100 | Essential amino acids formula with minerals and vitamin c | Oral powder 400 g (Dialamine) | Oral | Dialamine |
101 | Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal | Vagifem Low |
102 | Estradiol | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal | Sandrena |
103 | Estradiol | Transdermal patches 1.17 mg, 8 | Transdermal | Estradot 75 |
104 | Estradiol | Transdermal patches 1.56 mg, 8 | Transdermal | Estradot 100 |
105 | Estradiol | Transdermal patches 390 micrograms, 8 | Transdermal | Estradot 25 |
106 | Estradiol | Transdermal patches 585 micrograms, 8 | Transdermal | Estradot 37.5 |
107 | Estradiol | Transdermal patches 780 micrograms, 8 | Transdermal | Estradot 50 |
108 | Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal | Estalis sequi 50/250 |
109 | Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal | Estalis sequi 50/140 |
110 | Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/250 |
111 | Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/140 |
112 | Estriol | Pessaries 500 micrograms, 15 | Vaginal | Ovestin Ovula |
113 | Estriol | Vaginal Cream 1 mg per g, 15 g | Application | Ovestin |
114 | Ethosuximide | Capsule 250 mg | Oral | Zarontin |
115 | Etonogestrel | Subcutaneous implant 68 mg | Implantation | Implanon NXT |
116 | Etoposide | Capsule 50 mg | Oral | Vepesid |
117 | Etoposide | Capsule 100 mg | Oral | Vepesid |
118 | Fentanyl | Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal | Fentora |
119 | Fentanyl | Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal | Fentora |
120 | Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral | Ferro-Liquid |
121 | Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil |
122 | Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil |
123 | Flupentixol decanoate | Oily I.M. injection 20 mg in 1 mL | Injection | Fluanxol Depot |
124 | Flupentixol decanoate | Oily I.M. injection 100 mg in 1 mL | Injection | Fluanxol Concentrated Depot |
125 | Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by Mouth | Axotide Junior
|
126 | Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by Mouth | Flixotide Junior |
127 | Folinic acid | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral | Leucovorin Calcium (Hospira Pty Limited) |
128 | Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Gonal-f Pen |
129 | Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Ovaleap |
130 | Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre-filled syringe | Injection | Arixtra |
131 | Gentamicin | Injection 80 mg (as sulfate) in 2 mL | Injection | Pfizer Australia Pty Ltd |
132 | Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | GlucaGen Hypokit |
133 | Haloperidol | Injection 5 mg in 1 mL | Injection | Serenace |
134 | Haloperidol | Oral solution 2 mg per mL, 100 mL | Oral | Serenace |
135 | Haloperidol decanoate | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection | Haldol decanoate |
136 | Haloperidol decanoate | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection | Haldol decanoate |
137 | Hydrocortisone | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the Eye | Hycor |
138 | Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef |
139 | Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef |
140 | Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid |
141 | Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid |
142 | Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid |
143 | Imipramine | Tablet containing imipramine hydrochloride 25 mg | Oral | Tofranil 25 |
144 | Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Levemir FlexPen
|
145 | Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Levemir Penfill |
146 | Insulin glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Optisulin SoloStar
|
147 | Insulin glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Optisulin |
148 | Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection | Venofer |
149 | Ivermectin | Tablet 3 mg | Oral | Stromectol |
150 | Levodopa with benserazide | Capsule containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral | Madopar 62.5 |
151 | Levodopa with benserazide | Capsule containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar 125 |
152 | Levodopa with benserazide | Dispersible tablet containing levodopa 50 mg with 12.5 mg benserazide (as hydrochloride) | Oral | Madopar Rapid 62.5 |
153 | Levodopa with benserazide | Tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar 125 |
154 | Levodopa with carbidopa | Intestinal gel containing levodopa 20 mg with carbidopa monohydrate 5 mg per mL, 100 mL | Intra-intestinal | Duodopa |
155 | Levodopa with carbidopa | Tablet (modified release) 200 mg-50 mg (as monohydrate) | Oral | Sinemet CR |
156 | Levonorgestrel | Intrauterine drug delivery system 19.5 mg | Intrauterine | Kyleena |
157 | Levonorgestrel | Tablets 30 micrograms, 28 | Oral | Microlut 28 |
158 | Levothyroxine | Tablet containing 125 micrograms anhydrous levothyroxine sodium | Oral | Eltroxin |
159 | Lidocaine | Infusion containing lidocaine hydrochloride 500 mg in 5 mL | Injection | Xylocard 500 |
160 | Lidocaine | Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | Injection | Pfizer Australia Pty Ltd |
161 | Lithium | Tablet containing lithium carbonate 250 mg | Oral | Lithicarb |
162 | Lithium | Tablet containing lithium carbonate 450 mg (slow release) | Oral | Quilonum SR |
163 | Mannitol | Pack containing 280 capsules containing powder for inhalation 40 mg and 2 inhalers | Inhalation by Mouth | Bronchitol |
164 | Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | Depo-Ralovera |
165 | Medroxyprogesterone | Injection containing medroxyprogesterone acetate 150 mg in 1 mL | Injection | Depo-Provera |
166 | Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 10 mg | Oral | Ralovera |
167 | Medroxyprogesterone | Tablet containing medroxyprogesterone acetate 10 mg | Oral | Provera |
168 | Melphalan | Tablet 2 mg | Oral | Alkeran |
169 | Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 1 L | Oral | Aspen Methadone Syrup |
170 | Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 1 L | Oral | Biodone Forte |
171 | Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL | Oral | Aspen Methadone Syrup |
172 | Methadone | Oral liquid containing methadone hydrochloride 25 mg per 5 mL, 200 mL | Oral | Biodone Forte |
173 | Methadone | Tablet containing methadone hydrochloride 10 mg | Oral | Physeptone |
174 | Methotrexate | Tablet 2.5 mg | Oral | Methoblastin |
175 | Methotrexate | Tablet 10 mg | Oral | Methoblastin |
176 | Methyldopa | Tablet 250 mg (as sesquihydrate) | Oral | Aldomet |
177 | Milk powder -- synthetic | Low calcium oral powder 400 g (Locasol) | Oral | Locasol |
178 | Minocycline | Tablet 50 mg (as hydrochloride) | Oral | Minomycin-50 |
179 | Minocycline | Tablet 50 mg (as hydrochloride) | Oral | Akamin 50 |
180 | Morphine | Capsule containing morphine sulfate pentahydrate 10 mg (containing sustained release pellets) | Oral | Kapanol |
181 | Morphine | Tablet containing morphine sulfate pentahydrate 15 mg (controlled release) | Oral | MS Contin |
182 | Morphine | Tablet containing morphine sulfate pentahydrate 200 mg (controlled release) | Oral | MS Contin |
183 | Mycobacterium bovis (Bacillus Calmette and Guerin), Tice strain | Vial containing powder for intravesical administration approximately 5 x 108 CFU | Intravesical | OncoTICE |
184 | Nafarelin | Nasal spray (pump pack) 200 micrograms (as acetate) per dose, 60 doses | Nasal | Synarel |
185 | Naloxone | Nasal spray 1.8 mg (as hydrochloride dihydrate) in 0.1 mL single dose unit, 2 | Nasal | Nyxoid |
186 | Norethisterone | Tablet 5 mg | Oral | Primolut N |
187 | Nystatin | Capsule 500,000 units | Oral | Nilstat |
188 | Nystatin | Tablet 500,000 units | Oral | Nilstat |
189 | Oxycodone | Suppository 30 mg (as pectinate) | Rectal | Proladone |
190 | Peginterferon alfa-2a | Injection 135 micrograms in 0.5 mL single use pre-filled syringe | injection | Pegasys |
191 | Peginterferon alfa-2a | Injection 180 micrograms in 0.5 mL single use pre-filled syringe | injection | Pegasys |
192 | Perhexiline | Tablet containing perhexiline maleate 100 mg | Oral | Pexsig |
193 | Periciazine | Tablet 10 mg | Oral | Neulactil |
194 | Phenobarbital | Injection 200 mg (as sodium) in 1 mL | Injection | Phenobarbitone Injection (Aspen Pharmacare Australia Pty Ltd) |
195 | Phenoxymethylpenicillin | Powder for oral liquid 250 mg (as potassium) per 5 mL, 100 mL | Oral | Phenoxymethylpenicillin-AFT |
196 | Phenytoin | Capsule containing phenytoin sodium 30 mg | Oral | Dilantin Sodium |
197 | Phenytoin | Capsule containing phenytoin sodium 100 mg | Oral | Dilantin Sodium |
198 | Pilocarpine | Eye drops containing pilocarpine hydrochloride 10 mg per mL, 15 mL | Application to the eye | Isopto Carpine |
199 | Pilocarpine | Eye drops containing pilocarpine hydrochloride 20 mg per mL, 15 mL | Application to the eye | Isopto Carpine |
200 | Pilocarpine | Eye drops containing pilocarpine hydrochloride 40 mg per mL, 15 mL | Application to the eye | Isopto Carpine |
201 | Pizotifen | Tablet 500 micrograms (as malate) | Oral | Sandomigran 0.5 |
202 | Potassium chloride | Tablet 600 mg (sustained release) | Oral | Span-K |
203 | Potassium chloride with potassium bicarbonate | Tablet, effervescent, 14 mmol potassium and 8 mmol chloride | Oral | Chlorvescent |
204 | Primidone | Tablet 250 mg | Oral | Mysoline |
205 | Probenecid | Tablet 500 mg | Oral | Pro-Cid |
206 | Progesterone | Capsule 200 mg | Vaginal | Utrogestan |
207 | Progesterone | Pessary 100 mg | Vaginal | Oripro |
208 | Progesterone | Pessary 200 mg | Vaginal | Oripro |
209 | Propylthiouracil | Tablet 50 mg | Oral | PTU |
210 | Protein formula with carbohydrate, fat, vitamins and minerals | Oral liquid 500 mL, 12 (Nutrini Peptisorb Energy) | Oral | Nutrini Peptisorb Energy |
211 | Protein hydrolysate formula with medium chain triglycerides | Oral powder 400 g (Alfaré) | Oral | Alfaré |
212 | Protein hydrolysate formula with medium chain triglycerides | Oral powder 450 g (Aptamil Gold+ Pepti-Junior) | Oral | Aptamil Gold + Pepti Junior |
213 | Pyridostigmine | Tablet containing pyridostigmine bromide 10 mg | Oral | Mestinon |
214 | Quinine | Tablet containing quinine sulfate dihydrate 300 mg | Oral | Quinate |
215 | Raltitrexed | Powder for I.V. infusion 2 mg in single use vial | Injection | Tomudex |
216 | Reboxetine | Tablet 4 mg (as mesilate) | Oral | Edronax |
217 | Rifabutin | Capsule 150 mg | Oral | Mycobutin |
218 | Rivastigmine | Transdermal patch 9 mg | Transdermal | Exelon Patch 5 |
219 | Rivastigmine | Transdermal patch 18 mg | Transdermal | Exelon Patch 10 |
220 | Rivastigmine | Transdermal patch 27 mg | Transdermal | Exelon Patch 15 |
221 | Sirolimus | Tablet 0.5 mg | Oral | Rapamune |
222 | Sirolimus | Tablet 1 mg | Oral | Rapamune |
223 | Sirolimus | Tablet 2 mg | Oral | Rapamune |
224 | Sirolimus | Oral solution 1 mg per mL, 60 mL | Oral | Rapamune |
225 | Sodium acid phosphate | Tablet, compound effervescent, equivalent to 500 mg phosphorus | Oral | PHOSPHATE PHEBRA |
226 | Sodium bicarbonate | Capsule 840 mg | Oral | Sodibic |
227 | Soy protein and fat formula with vitamins and minerals -- carbohydrate free | Oral liquid 384 mL (RCF) | Oral | RCF |
228 | Sulfasalazine | Tablet 500 mg (enteric coated) | Oral | Pyralin EN |
229 | Sulfasalazine | Tablet 500 mg (enteric coated) | Oral | Salazopyrin EN |
230 | Sulfasalazine | Tablet 500 mg | Oral | Salazopyrin |
231 | Sulthiame | Tablet 50 mg | Oral | Ospolot |
232 | Sulthiame | Tablet 200 mg | Oral | Ospolot |
233 | Sumatriptan | Nasal spray 20 mg in 0.1 mL single dose unit | Nasal | Imigran |
234 | Tenecteplase | Powder for injection 40 mg with solvent | Injection | Metalyse |
235 | Tenecteplase | Powder for injection 50 mg with solvent | Injection | Metalyse |
236 | Terbutaline | Powder for oral inhalation in breath actuated device containing terbutaline sulfate 500 micrograms per dose, 120 doses | Inhalation by Mouth | Bricanyl Turbuhaler |
237 | Testosterone | Transdermal cream 50 mg per mL, 50 mL | Transdermal | AndroForte 5 |
238 | Testosterone | Transdermal gel (pump pack) 12.5 mg per 1.25 g dose, 60 doses, 2 | Transdermal | Testogel |
239 | Testosterone | Transdermal gel (pump pack) 23 mg per 1.15 g dose, 56 doses | Transdermal | Testavan |
240 | Testosterone | Transdermal gel 50 mg in 5 g sachet, 30 | Transdermal | Testogel |
241 | Tetrabenazine | Tablet 25 mg | Oral | iNova Pharmaceuticals (Australia) Pty Ltd |
242 | Theophylline | Tablet 200 mg (sustained release) | Oral | Nuelin-SR 200 |
243 | Theophylline | Tablet 250 mg (sustained release) | Oral | Nuelin-SR 250 |
244 | Theophylline | Tablet 300 mg (sustained release) | Oral | Nuelin-SR 300 |
245 | Theophylline | Oral solution 133.3 mg per 25 mL, 500 mL | Oral | Nuelin |
246 | Tiagabine | Tablet 5 mg (as hydrochloride) | Oral | Gabitril |
247 | Tiagabine | Tablet 10 mg (as hydrochloride) | Oral | Gabitril |
248 | Tiagabine | Tablet 15 mg (as hydrochloride) | Oral | Gabitril |
249 | Tioguanine | Tablet 40 mg | Oral | Lanvis |
250 | Tobramycin | Capsule containing powder for oral inhalation 28 mg (for use in podhaler) | Inhalation by Mouth | TOBI podhaler |
251 | Tobramycin | Eye drops 3 mg per mL, 5 mL | Application to the Eye | Tobrex |
252 | Tobramycin | Eye ointment 3 mg per g, 3.5 g | Application to the Eye | Tobrex |
253 | Triamcinolone | Injection containing triamcinolone acetonide 10 mg in 1 mL | Injection | Kenacort-A10 |
254 | Triglycerides, medium chain | Oil 500 mL (MCT Oil) | Oral | MCT Oil |
255 | Triglycerides, medium chain | Oral emulsion 250 mL (Liquigen) | Oral | Liquigen |
256 | Triglycerides - medium chain, formula | Oral liquid 500 mL, 8 (Nutrini Peptisorb) | Oral | Nutrini Peptisorb |
257 | Triglycerides - medium chain, formula | Oral powder 400 g (Monogen) | Oral | Monogen |
258 | Triglycerides, medium chain and long chain with glucose polymer | Oral powder 400 g (Duocal) | Oral | Duocal |
259 | Varenicline | Tablet 1 mg (as tartrate) (s19A) | Oral | APO-Varenicline |
260 | Vinblastine | Solution for I.V. injection containing vinblastine sulfate 10 mg in 10 mL | Injection | DBL Vinblastine |
261 | Vinorelbine | Capsule 20 mg (as tartrate) | Oral | Navelbine |
262 | Vinorelbine | Capsule 30 mg (as tartrate) | Oral | Navelbine |
263 | Vitamins, minerals and trace elements formula | Sachets containing oral powder 7 g, 30 (Phlexy-Vits) | Oral | Phlexy-Vits |
264 | Whey protein formula supplemented with amino acids, vitamins and minerals, and low in protein, phosphate, potassium and lactose | Oral powder 400 g (Kindergen) | Oral | Kindergen |
265 | Zidovudine | Syrup 10 mg per mL, 200 mL | Oral | Retrovir |
266 | Zuclopenthixol decanoate | Oily I.M. injection 200 mg in 1 mL | Injection | Clopixol Depot |
Schedule 3 — Brands of pharmaceutical items with approved ex-manufacturer price reduced by a lower percentage than would otherwise apply
Column 1 | Column 2 | Column 3 | |||
Item | Brand of pharmaceutical item | % reduction | |||
| Drug | Form | Manner of administration | Brand |
|
1 | Budesonide | Rectal foam 2 mg per application, 14 applications, aerosol 16.8 g, 2 | Rectal | Budenofalk | 10% |
2 | Cetuximab | Solution for I.V. infusion 100 mg in 20 mL | Injection | Erbitux | 7.9%
|
3 | Cetuximab | Solution for I.V. infusion 500 mg in 100 mL | Injection | Erbitux | 7.9% |
4 | Clonidine | Tablet containing clonidine hydrochloride 150 micrograms | Oral | Catapres | 14.04% |
5 | Fentanyl | Lozenge 200 micrograms (as citrate) | Buccal | Actiq | 13% |
6 | Fentanyl | Lozenge 400 micrograms (as citrate) | Buccal | Actiq | 13% |
7 | Fentanyl | Tablet (sublingual) 100 micrograms (as citrate) | Sublingual | Abstral | 14% |
8 | Fentanyl | Tablet (sublingual) 200 micrograms (as citrate) | Sublingual | Abstral | 14% |
9 | Fentanyl | Tablet (sublingual) 300 micrograms (as citrate) | Sublingual | Abstral | 14% |
10 | Fentanyl | Tablet (sublingual) 400 micrograms (as citrate) | Sublingual | Abstral | 14% |
11 | Fentanyl | Tablet (sublingual) 600 micrograms (as citrate) | Sublingual | Abstral | 14% |
12 | Fentanyl | Tablet (sublingual) 800 micrograms (as citrate) | Sublingual | Abstral | 14% |
13 | Ferrous fumarate with folic acid | Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms | Oral | Ferro-f-tab | 5% |
14 | Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral | Fucidin | 14% |
15 | Glibenclamide | Tablet 5 mg | Oral | Daonil | 13% |
16 | Levodopa with benserazide | Capsule containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral | Madopar | 18% |
17 | Levodopa with benserazide | Dispersible tablet containing levodopa 100 mg with 25 mg benserazide (as hydrochloride) | Oral | Madopar Rapid 125 | 5% |
18 | Levodopa with benserazide | Tablet containing levodopa 200 mg with 50 mg benserazide (as hydrochloride) | Oral | Madopar | 18% |
19 | Mesalazine | Enemas 4 g in 60 mL, 7 | Rectal | Salofalk | 10% |
20 | Mesalazine | Rectal foam 1 g per applicatorful, 14 applications, aerosol 80 g | Rectal | Salofalk | 10% |
21 | Mesalazine | Suppository (moulded) 1 g | Rectal | Salofalk | 10% |
22 | Mesalazine | Tablet 1 g (enteric coated) | Oral | Salofalk | 10% |
23 | Methylphenidate | Capsule containing methylphenidate hydrochloride 10 mg (modified release) | Oral | Ritalin LA | 11.33% |
24 | Methylphenidate | Capsule containing methylphenidate hydrochloride 60 mg (modified release) | Oral | Ritalin LA | 11.33% |
25 | Morphine | Oral solution containing morphine hydrochloride trihydrate 2 mg per mL, 200 mL | Oral | Ordine 2 | 4% |
26 | Morphine | Oral solution containing morphine hydrochloride trihydrate 5 mg per mL, 200 mL | Oral | Ordine 5 | 10% |
27 | Morphine | Oral solution containing morphine hydrochloride trihydrate 10 mg per mL, 200 mL | Oral | Ordine 10 | 6% |
28 | Morphine | Tablet containing morphine sulfate pentahydrate 5 mg (controlled release) | Oral | MS Contin | 8% |
29 | Morphine | Tablet containing morphine sulfate pentahydrate 10 mg | Oral | Sevredol | 2% |
30 | Morphine | Tablet containing morphine sulfate pentahydrate 20 mg | Oral | Sevredol | 2% |
31 | Somatropin | Injection 0.4 mg (1.2 i.u.) with diluent in single use syringe (without preservative) | Injection | Genotropin Miniquick | 24.79% |
32 | Thyrotropin alfa | Powder for injection 0.9 mg, 2 | Injection | Thyrogen | 5% |